The identification of cancer types driven by CAF-1 and the elucidation of the molecular mechanisms linking CAF-1 with tumorigenesis may lead to the development of new therapeutic tools targeting CAF-1 in selected subsets of cancer patients. The gene discussed is CHAF1A; the disease is cancer.